NARS FOUNDATION description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

NARS FOUNDATION

NARS COSMETICS

NARS POWDER FOUNDATION


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredient

Purpose

Active ingredients Purpose
OCTINOXATE 4.9% Sunscreen
TITANIUM DIOXIDE 6.6% Sunscreen

NARS FOUNDATION Uses

  • helps prevent sunburn

Warnings

Skin Cancer/Skin Aging Alert

Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging.

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • reapply at least every 2 hours
  • children under 6 months: Ask a doctor

Inactive Ingredients

NYLON-12 , CALCIUM STEARATE , SILICA , DIMETHICONE , JOJOBA ALCOHOL , ISOPROPYL JOJOBATE , JOJOBA ESTERS , HYDROGENATED LECITHIN , TRIMETHYLSILOXYSILICATE , LAUROYL LYSINE , METHICONE , SORBITAN SESQUIOLEATE , METHYLPARABEN , PROPYLPARABEN , BHT , TOCOPHEROL , [(MAY CONTAIN): MICA , TITANIUM DIOXIDE , IRON OXIDES , IRON OXIDES , IRON OXIDES] ,

NARS FOUNDATION Other information

protect this product in this container from excessive heat and direct sun

Questions or comments?

Call toll free 1-888-788-NARS

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - BARCELONA

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - BENARES

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - CÁDIZ

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - DEAUVILLE

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - FIJI

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - MONT BLANC

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - NEW ORLEANS

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - PUNJAB

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - SANTA FE

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - SIBERIA

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - STROMBOLI

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - SYRACUSE

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - TAHOE

NARS

POWDER FOUNDATION BROAD SPECTRUM
SPF 12 SUNSCREEN

NET WT. 0.42 Oz. 12 g

NARS FOUNDATION

NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-114
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-114-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-115
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-115-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-116
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-116-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-117
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-117-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-118
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-118-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-119
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-119-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-120
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-120-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-121
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-121-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-122
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-122-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-123
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-123-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-124
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-124-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-125
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-125-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


NARS FOUNDATION

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13734-126
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 588 mg
titanium dioxide 792 mg

Inactive Ingredients

Ingredient Name Strength
NYLON-12
CALCIUM STEARATE
SILICON DIOXIDE
DIMETHICONE
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)
LAUROYL LYSINE
METHICONE (20 CST)
SORBITAN SESQUIOLEATE
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
MICA
titanium dioxide
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TRAY
2 NDC:13734-126-30 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2012-12-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.